Expression of the pluripotency transcription factor OCT4 in the normal and aberrant mammary gland

Frontiers in Oncology

Volumn 3 APR, Issue , 2013, Pages

  Hassiotou, Foteini ^a   Hepworth, Anna R ^a   Beltran, Adriana S ^b   Mathews, Michelle M ^b   Stuebe, Alison M ^b   Hartmann, Peter E ^a   Filgueira, Luis ^a,c   Blancafort, Pilar ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Adult stem cell; Breast cancer; Breastmilk; Cancer stem cell; Mammary gland; OCT4; Self renewal; Transcription factors

Indexed keywords

BETA TUBULIN; CYTOKERATIN 14; DESMIN; EPITHELIAL CELL ADHESION MOLECULE; MILK PROTEIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; OV6 PROTEIN; PEPTIDES AND PROTEINS; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; BREAST CANCER; BREAST MILK; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LACTATION; MAMMARY GLAND; PREGNANCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84890634153     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00079     Document Type: Article

References (34)

1. Akaogi, K., Nakajima, Y., Ito, I., Kawasaki, S., Oie, S. H., Murayama, A., et al. (2009). KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Oncogene 28, 2894-2902.
2. Arnold, K., Sarkar, A., Yram, M. A., Polo, J. M., Bronson, R., Sengupta, S., et al. (2011). Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 9, 317-329.
3. Barnes, D. M., and Newman, L. A. (2007). Pregnancy-associated breast cancer: a literature review. Surg. Clin. North Am. 87, 417-430.
4. Beltran, A. S., Rivenbark, A. G., Richardson, B. T., Yuan, X., Quian, H., Hunt, J. P., et al. (2011). Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Res. 13, R94.
5. Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507.
6. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956.
7. Conrad, S., Renninger, M., Hennenlotter, J., Wiesner, T., Just, L., Bonin, M., et al. (2008). Generation of pluripotent stem cells from adult human testis. Nature 456, 344-349.
8. Gentilini, O., Masullo, M., Rotmensz, N., Peccatori, F., Mazzarol, G., Smeets, A., et al. (2005). Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur. J. Surg. Oncol. 31, 232-236.
9. Hassiotou, F., Beltran, A., Chetwynd, E., Stuebe, A. M., Twigger, A. J., Metzger, P., et al. (2012). Breastmilk is a novel source of stem cells with multi-lineage differentiation potential. Stem Cells 30, 2164-2174.
10. Keinan-Boker, L., Lerner-Geva, L., Kaufman, B., and Meirow, D. (2008). Pregnancy-associated breast cancer. Isr. Med. Assoc. J. 10, 722-727.
11. Keleher, A. J., Theriault, R. L., Gwyn, K. M., Hunt, K. K., Stelling, C. B., Singletary, S. E., et al. (2002). Multidisciplinary management of breast cancer concurrent with pregnancy. J. Am. Coll. Surg. 194, 54-64.
12. Kumar, S. M., Liu, S., Lu, H., Zhang, H., Zhang, P. J., Gimotty, P. A., et al. (2012). Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 31, 4898-4911.
13. Kuroda, Y., Kitada, M., Wakao, S., Nishikawa, K., Tanimura, Y., Makinoshima, H., et al. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proc. Natl. Acad. Sci. U.S.A. 107, 8639-8643.
14. Leis, O., Eguiara, A., Lopez-Arribillaga, E., Alberdi, M. J., Hernandez-Garcia, S., Elorriaga, K., et al. (2012). Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31, 1354-1365.
15. Lengerke, C., Fehm, T., Kurth, R., Neubauer, H., Scheble, V., Muller, F., et al. (2011). Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11:42. doi:10.1186/1471-2407-11-42
16. Lensch, M. W., Schlaeger, T. M., Zon, L. I., and Daley, G. Q. (2007). Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 1, 253-258.
17. Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., et al. (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913.
18. Liu, C., Cao, X., Zhang, Y., Xu, H., Zhang, R., Wu, Y., et al. (2012). Co-expression of Oct-4 and Nestin in human breast cancers. Mol. Biol. Rep. 39, 5875-5881.
19. Liu, C. G., Lu, Y., Wang, B. B., Zhang, Y. J., Zhang, R. S., Chen, B., et al. (2011). Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann. Surg. 253, 1165-1171.
20. Matthai, C., Horvat, R., Noe, M., Nagele, F., Radjabi, A., van Trotsenburg, M., et al. (2006). Oct-4 expression in human endometrium. Mol. Hum. Reprod. 12, 7-10.
21. Molenaar, A. J., Davis, S. R., and Wilkins, R. J. (1992). Expression of a-lactalbumin, a-S1-casein, and lactoferrin genes is heterogeneous in sheep and cattle mammary tissue. J. Histochem. Cytochem. 40, 611-618.
22. Monk, M., and Holding, C. (2001). Human embryonic genes re-expressed in cancer cells. Oncogene 20, 8085-8091.
23. Nagata, T., Shimada, Y., Sekine, S., Hori, R., Matsui, K., Okumura, T., et al. (2012). Prognostic significance of NANOG and KLF4 for breast cancer. Breast Cancer. doi:10.1007/s12282-012-0357-y. [Epub ahead of print].
24. Nakatsugawa, M., Takahashi, A., Hirohashi, Y., Torigoe, T., Inoda, S., Murase, M., et al. (2011). SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab. Invest. 91, 1796-1804.
25. Prat, A., and Perou, C. M. (2009). Mammary development meets cancer genomics. Nat. Med. 15, 842-844.
26. R Development Core Team (2009). R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing.
27. Ratajczak, M. Z., Liu, R., Ratajczak, J., Kucia, M., and Shin, D. M. (2011). The role of pluripotent embryonic-like stem cells residing in adult tissues in regeneration and longevity. Differentiation 81, 153-161.
28. Roy, S., Gascard, P., Dumont, N., Zhao, J., Pan, D., Petrie, S., et al. (2013). Rare somatic cells from human breast tissue exhibit extensive lineage plasticity. Proc. Natl. Acad. Sci. U S A 110, 4598-4603.
29. Sterneckert, J., Hoing, S., and Scholer, H. R. (2012). Concise review: Oct4 and more: the reprogramming expressway. Stem Cells 30, 15-21.
30. Tai, M. H., Chang, C. C., Kiupel, M., Webster, J. D., Olson, L. K., and Trosko, J. E. (2005). Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26, 495-502.
31. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
32. Thomas, E., Lee-Pullen, T., Rigby, P., Hartmann, P., Xu, J., and Zeps, N. (2012). Receptor activator of NF-kappaB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium. Stem Cells 30, 1255-1264.
33. Tiede, B., and Kang, Y. (2011). From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res. 21, 245-257.
34. Young, R. A. (2011). Control of the embryonic stem cell state. Cell 144, 940-954.